Literature DB >> 832895

Immunogenic activity of a ribosomal fraction obtained from Pasteurella multocida.

T Baba.   

Abstract

The cells of P. multocida strain P-1059 were destroyed with the French pressure cell; the ribosomal fraction proven to be homogeneous by analytical ultracentrifugation was obtained from the product by centrifugal fractionation, zonal electrophoresis, and Sephadex G-200 gel filtration. The ribosomal fraction exhibited intense protective antigenicity in mice and chickens, but the lipopolysaccharide (endotoxin) and the other bacterial cell fraction obtained in this experiment did not. Sodium deoxycholate treatment of the ribosomal fraction resulted in only a 13% loss in immunological activity, and ribonuclease treatment caused a 60% loss of activity.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 832895      PMCID： PMC421321          DOI： 10.1128/iai.15.1.1-6.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  16 in total

1.  The relationship between sedimentation value and immunogenic acitivity of mycobacterial ribonucleic acid.

Authors:  A S Youmans; G P Youmans
Journal:  J Immunol       Date:  1973-02       Impact factor: 5.422

2.  Isolation of protective somatic antigen from Vibrio cholerae (Ogawa) ribosomal preparations.

Authors:  R Jensen; B Gregory; J Naylor; P Actor
Journal:  Infect Immun       Date:  1972-08       Impact factor: 3.441

3.  Preparation and effect of different adjuvants on the immunogenic activity of mycobacterial ribosomal fraction.

Authors:  A S Youmans; G P Youmans
Journal:  J Bacteriol       Date:  1967-10       Impact factor: 3.490

4.  Factors affecting immunogenic activity of mycobacterial ribosomal and ribonucleic acid preparations.

Authors:  A S Youmans; G P Youmans
Journal:  J Bacteriol       Date:  1969-07       Impact factor: 3.490

5.  Immunity induced by ribosomal extracts from Staphylococcus aureus.

Authors:  S Winston; L J Berry
Journal:  J Reticuloendothel Soc       Date:  1970-07

6.  Immunogenicity of ribosomal vaccines isolated from group A, type 14 Streptococcus pyogenes.

Authors:  W O Schalla; W Johnson
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

7.  Isolation and partial characterization of an immunogenic moiety obtained from Salmonella typhimurium.

Authors:  M R Venneman; N J Bigley
Journal:  J Bacteriol       Date:  1969-10       Impact factor: 3.490

8.  Preparation of highly immunogenic ribosomal fractions of Mycobacterium tuberculosis by use of sodium dodecyl sulfate.

Authors:  A S Youmans; G P Youmans
Journal:  J Bacteriol       Date:  1966-06       Impact factor: 3.490

9.  Response of mice to injection of ribosomal fraction from group B Neisseria meningitidis.

Authors:  D W Thomas; E Weiss
Journal:  Infect Immun       Date:  1972-09       Impact factor: 3.441

10.  Isolation from Pasteurella multocida of a lipopolysaccharide antigen with immunizing and toxic properties.

Authors:  P A Rebers; K L Heddleston; K R Rhoades
Journal:  J Bacteriol       Date:  1967-01       Impact factor: 3.490
View more
  10 in total

1.  Characterization of the immunoprotective antigen of ribosomal preparations from Haemophilus influenzae.

Authors:  R P Tewari; M Lynn; A J Birnbaum; M Solotorovsky
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

2.  Direct evidence for the presence of lipopolysaccharide components in Pseudomonas ribosomal vaccine.

Authors:  M M Lieberman
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

3.  Passive immunization against Pseudomonas with a ribosomal vaccine-induced immune serum and immunoglobulin fractions.

Authors:  M M Lieberman; D C McKissock; G L Wright
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

4.  Pseudomonas ribosomal vaccines: preparation, properties, and immunogenicity.

Authors:  M M Lieberman
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

5.  Identification of Mycobacterial RplJ/L10 and RpsA/S1 Proteins as Novel Targets for CD4+ T Cells.

Authors:  Alison J Johnson; Steven C Kennedy; Cecilia S Lindestam Arlehamn; Michael F Goldberg; Neeraj K Saini; Jiayong Xu; Sinu Paul; Subray S Hegde; John S Blanchard; John Chan; William R Jacobs; Alessandro Sette; Steven A Porcelli
Journal:  Infect Immun       Date:  2017-03-23       Impact factor: 3.441

6.  Capsular serotypic specificity of the protection conferred on mice by Klebsiella pneumoniae ribosomal preparations.

Authors:  M Riottot; J M Fournier; J Pillot
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

7.  Ribonuclease-sensitive ribosomal vaccines.

Authors:  R Gonggrijp; A C Antonissen; J F van den Bosch; C P van Boven
Journal:  Antonie Van Leeuwenhoek       Date:  1984       Impact factor: 2.271

8.  Direct evidence for the involvement of capsular polysaccharide in the immunoprotective activity of Klebsiella pneumoniae ribosomal preparations.

Authors:  M M Riottot; J M Fournier; H Jouin
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

9.  Intranasal immunization of mice against Pasteurella multocida.

Authors:  R H Smith; L A Babiuk; P H Stockdale
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

10.  Purification of a protective antigen from a saline extract of Pasteurella multocida.

Authors:  B Syuto; M Matsumoto
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.